https://orcid.org/0000-0002-4881-720X
References
- Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008. doi: 10.1161/01.cir.0000047200.36165.b8.
- Bevan GH, Zidar DA, Josephson RA, et al. Mortality due to aortic stenosis in the United States, 2008–2017. JAMA. 2019;321(22):2236–2238. doi: 10.1001/jama.2019.6292.
- Heen AF, Lytvyn L, Shapiro M, et al. Patient values and preferences on valve replacement for aortic stenosis: a systematic review. Heart. 2021;107(16):1289–1295. doi: 10.1136/heartjnl-2020-318334.
- Petrou P. The economics of TAVI: a systematic review. Int J Cardiol Heart Vasc. 2023;44:101173. doi: 10.1016/j.ijcha.2023.101173.
- Kobayashi J, Baron SJ, Takagi K, et al. Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan. J Med Econ. 2024;27(1):697–707. doi: 10.1080/13696998.2024.2346397.
- Kodera S, Kiyosue A, Ando J, et al. Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan. J Cardiol. 2018;71(3):223–229. doi: 10.1016/j.jjcc.2017.10.008.
- Sadri V, Trusty PM, Madukauwa-David ID, et al. Long-term durability of a new surgical aortic valve: a 1 billion cycle in vitro study. JTCVS Open. 2021;9:59–69. doi: 10.1016/j.xjon.2021.10.056.